Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. WRB
WRB logo

WRB Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy W R Berkley Corp (WRB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
65.700
1 Day change
-2.25%
52 Week Range
78.960
Analysis Updated At
2026/04/10
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

W. R. Berkley Corp is not a strong buy for a beginner, long-term investor at this time. The stock shows limited growth potential in the near term, with analysts downgrading ratings and lowering price targets. Additionally, recent financial performance shows declining net income and EPS, despite modest revenue growth. While the company has long-term growth potential, current technical and sentiment indicators do not suggest an optimal entry point for investment.

Technical Analysis

The MACD histogram is positive and expanding, indicating a bullish momentum. RSI is neutral at 64.815, and moving averages are converging, showing no clear trend. The stock is trading near resistance levels (R1: 67.471), suggesting limited upside potential in the short term.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
12
Buy
1

Positive Catalysts

  • The company has demonstrated a 12.4% annual growth in net premiums earned over five years and a 33% annual increase in EPS due to share repurchases. Analysts acknowledge solid margins and strong capital deployment contributing to book value growth.

Neutral/Negative Catalysts

  • Analysts have downgraded the stock and lowered price targets, citing slowing growth and softening market conditions. Financial performance in Q4 2025 showed a significant decline in net income (-21.97%) and EPS (-21.53%). Stock trend analysis predicts a potential decline of -9.47% in the next month.

Financial Performance

In Q4 2025, revenue increased by 4.03% YoY to $3.81 billion. However, net income dropped by 21.97% YoY to $449.51 million, and EPS declined by 21.53% YoY to $1.13. Gross margin remained flat.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have downgraded the stock to Neutral or Underweight, with price targets reduced to a range of $62-$73. They cite slowing growth in the insurance sector and softening market conditions as key concerns.

Wall Street analysts forecast WRB stock price to rise
12 Analyst Rating
Wall Street analysts forecast WRB stock price to rise
2 Buy
7 Hold
3 Sell
Hold
Current: 67.210
sliders
Low
64
Averages
72.25
High
84
Current: 67.210
sliders
Low
64
Averages
72.25
High
84
Cantor Fitzgerald
Ryan Tunis
Overweight
to
Neutral
downgrade
$75 -> $71
AI Analysis
2026-04-09
New
Reason
Cantor Fitzgerald
Ryan Tunis
Price Target
$75 -> $71
AI Analysis
2026-04-09
New
downgrade
Overweight
to
Neutral
Reason
Cantor Fitzgerald analyst Ryan Tunis downgraded W. R. Berkley to Neutral from Overweight with a price target of $71, down from $75, as part of a Q1 earnings preview. There is a "huge" excess and surplus component to W. R. Berkley's business that will more evident as the company "struggles to grow in 2026," the analyst tells investors in a research note. Cantor views this as a catalyst for a de-rating of the shares.
Cantor Fitzgerald
Overweight
to
Neutral
downgrade
$75 -> $71
2026-04-09
New
Reason
Cantor Fitzgerald
Price Target
$75 -> $71
2026-04-09
New
downgrade
Overweight
to
Neutral
Reason
Cantor Fitzgerald downgraded W. R. Berkley to Neutral from Overweight with a price target of $71, down from $75.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for WRB
Unlock Now

People Also Watch